Cargando…
Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents
Autor principal: | Long, Sarah S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440228/ https://www.ncbi.nlm.nih.gov/pubmed/34332972 http://dx.doi.org/10.1016/j.jpeds.2021.07.057 |
Ejemplares similares
-
COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022) -
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021) -
Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent
por: Umei, Tomohiko C., et al.
Publicado: (2021) -
A Case of Myopericarditis After the Second Dose of mRNA COVID-19
Vaccine in a Patient With a History of Myopericarditis
por: Fujibayashi, Kosuke, et al.
Publicado: (2022) -
A case of myopericarditis following administration of the Pfizer COVID-19 vaccine
por: Morton, Zoey, et al.
Publicado: (2022)